Julie Wagner1, Howard Tennen, Howard Wolpert. 1. Behavioral Sciences and Community Health, University of Connecticut Health Center, Farmington, CT 06405, USA. juwagner@uchc.edu
Abstract
OBJECTIVE: Continuous glucose monitoring (CGM) systems collect and store glucose data in an ongoing fashion for several days at a time. The main advantage of CGM is that it can help identify fluctuations and trends that would otherwise go unnoticed with other glucose measures. Here, we provide a review of CGM for behavioral researchers. METHODS: We begin with a brief review of diabetes and glucose measurement and then describe what CGM is and reference the commercial CGM systems currently available. We discuss the challenges involved in using CGM in behavioral research. We then present a broad overview of CGM in behavioral research, including data from ours and others' research programs. Finally, we cover some practical issues to be considered when using CGM, suggest reporting guidelines for the behavioral researcher, and offer suggestions for future research. RESULTS: Only a handful of behavioral researchers are using CGM, although its use is increasing. The main ways that CGM is being used in behavioral research is to investigate basic biobehavioral processes, to assess the effects of behavioral interventions on diabetes control, and to use CGM itself as a behavior modification and teaching tool in diabetes self-management interventions. CONCLUSIONS: Continuous glucose monitoring holds promise to help behavioral researchers unravel the complex relationships among glucose and intrapersonal, interpersonal, and contextual factors. However, the uptake of CGM for this purpose is limited, and the possibilities for its use are largely unmet. We encourage behavioral researchers to implement CGM in their protocols and to do so in a way that maximizes its explanatory power.
OBJECTIVE:Continuous glucose monitoring (CGM) systems collect and store glucose data in an ongoing fashion for several days at a time. The main advantage of CGM is that it can help identify fluctuations and trends that would otherwise go unnoticed with other glucose measures. Here, we provide a review of CGM for behavioral researchers. METHODS: We begin with a brief review of diabetes and glucose measurement and then describe what CGM is and reference the commercial CGM systems currently available. We discuss the challenges involved in using CGM in behavioral research. We then present a broad overview of CGM in behavioral research, including data from ours and others' research programs. Finally, we cover some practical issues to be considered when using CGM, suggest reporting guidelines for the behavioral researcher, and offer suggestions for future research. RESULTS: Only a handful of behavioral researchers are using CGM, although its use is increasing. The main ways that CGM is being used in behavioral research is to investigate basic biobehavioral processes, to assess the effects of behavioral interventions on diabetes control, and to use CGM itself as a behavior modification and teaching tool in diabetes self-management interventions. CONCLUSIONS:Continuous glucose monitoring holds promise to help behavioral researchers unravel the complex relationships among glucose and intrapersonal, interpersonal, and contextual factors. However, the uptake of CGM for this purpose is limited, and the possibilities for its use are largely unmet. We encourage behavioral researchers to implement CGM in their protocols and to do so in a way that maximizes its explanatory power.
Authors: C Berndt-Zipfel; L Köthe; B Nawrodt; B Mraz; A Patzelt-Bath; M A Nauck Journal: Exp Clin Endocrinol Diabetes Date: 2011-01-18 Impact factor: 2.949
Authors: Arthur A Stone; Joan E Broderick; Joseph E Schwartz; Saul Shiffman; Leighann Litcher-Kelly; Pamela Calvanese Journal: Pain Date: 2003-07 Impact factor: 6.961
Authors: Edmond A Ryan; Tami Shandro; Kristy Green; Breay W Paty; Peter A Senior; David Bigam; A M James Shapiro; Marie-Christine Vantyghem Journal: Diabetes Date: 2004-04 Impact factor: 9.461
Authors: Michelle L Litchman; Ashley Ng; Ana Sanchez-Birkhead; Nancy A Allen; Bruno Rodriguez-Gonzales; Eli Iacob; Deborah A Greenwood Journal: J Diabetes Sci Technol Date: 2021-08-20
Authors: Paddy C Dempsey; Jennifer M Blankenship; Robyn N Larsen; Julian W Sacre; Parneet Sethi; Nora E Straznicky; Neale D Cohen; Ester Cerin; Gavin W Lambert; Neville Owen; Bronwyn A Kingwell; David W Dunstan Journal: Diabetologia Date: 2016-12-09 Impact factor: 10.122
Authors: Stephanie Griggs; Margaret Grey; Kingman P Strohl; Sybil L Crawford; Seunghee Margevicius; Sangeeta R Kashyap; Chiang-Shan R Li; Sanjay Rajagopalan; Ronald L Hickman Journal: J Clin Endocrinol Metab Date: 2022-02-17 Impact factor: 5.958
Authors: Stephanie Griggs; Ronald L Hickman; Kingman P Strohl; Nancy S Redeker; Sybil L Crawford; Margaret Grey Journal: J Clin Sleep Med Date: 2021-09-01 Impact factor: 4.324
Authors: Stephanie J Fonda; Sara J Salkind; M Susan Walker; Mary Chellappa; Nicole Ehrhardt; Robert A Vigersky Journal: Diabetes Care Date: 2012-11-19 Impact factor: 19.112
Authors: Stephanie Griggs; Kingman P Strohl; Margaret Grey; Eric Barbato; Seunghee Margevicius; Ronald L Hickman Journal: Chronobiol Int Date: 2021-06-15 Impact factor: 3.749